Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp

NCT02406014 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

502

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis (AK)

Interventions

DRUG: Ingenol Mebutate Gel, 0.015%
DRUG: Diclofenac sodium gel 3%

Sponsor

LEO Pharma